The Hindu Business Line : Emami acquires controlling stake in Zandu

Kolkata, Oct. 16 The Parikh family, the existing promoters of The Zandu Pharmaceuticals Works Ltd, has agreed to sell 18.18 per cent strategic stake to Emami Ltd at a total price of Rs 242 crore, including a non-compete fee of Rs 22 crore. This off-market deal with Parikhs signed on Wednesday and two other market deals, which gave it additional 4.64 per cent, allowed Emami to gain control of Zandu.

Mr Harsh V. Agarwal, Executive Director of Emami, told Business Line that apart from the response figure to the open offer, which has just concluded, Emami group now controlled a total of over 50 per cent stake in Zandu. Mr Agarwal was hopeful that the open offer for 20 per cent would be successful in terms of mopping up of shares. He said the exact response to the open offer would only be known next week. Interestingly, if the acquirers’ holding crosses 55 per cent, they would have to make another open offer under the SEBI rules.

According to sources involved in the deal, through an off-market deal, a total of 1,46,643 equity shares are being bought at a price of Rs 15,000 a share and also a non-compete fee of Rs 1,500 a equity share from majority of the five factions of the Parikh family. The deal, however, left out holdings worth 2 per cent, as some members did not take part in the agreement.

According Mr Rohit Kothari, CEO of Antique Financial Ltd, financial advisor to the deal for the Parikhs, “It was an amicable takeover in a short time and a fantastic exit valuation for the promoters.”

Little over four months of negotiations between Emami and the Parikhs were spearheaded by Antique and Anand Rathi Financial Services, financial advisors to Emami group, and continued side by side with legal wrangles.

Formalisation of change in control of Zandu would take a few days as it would require completion of payments to the Parikhs and reconstitution of board. Sources expect that the next Zandu board meeting may take place within a fortnight. Holding of the AGM for 2007-08, which was postponed twice, would be a priority for the new board.

Related Stories:
Emami ups open offer price for Zandu to Rs 16,500 a share
Zandu Pharma scales new peak
Emami comes out with open offer for Zandu

More Stories on : Pharmaceuticals | Mergers & Acquisitions | Personal Products

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
CCEA clears Rs 50 a quintal paddy bonus

Westerly system triggers rains over northwest

No retrenchment, only leave without pay for AI staff

Inflation worries recede as number hits 18-week low

No fuel price cut for now: Deora

Emami acquires controlling stake in Zandu

Union Bank of India (Rs 161.60): Buy

Day Trading Guide

HDFC Bank Q2 net up 43% on higher interest income

Tata Motors rights issue gets lukewarm response

HCL Tech buys over 10% stake in Axon

Net interest margins of banks to rise in Q3

Sensex dips 227, trims early losses on fall in inflation

FIIs’ selling touches $11 b